Regencell Bioscience Stock (NASDAQ:RGC)
Previous Close
$18.83
52W Range
$9.39 - $81.23
50D Avg
$26.49
200D Avg
$22.44
Market Cap
$8.45B
Avg Vol (3M)
$129.96K
Beta
1.64
Div Yield
-
RGC Company Profile
Regencell Bioscience Holdings Limited is a biotechnology firm specializing in Traditional Chinese Medicine (TCM). Its core activities revolve around the research, development, and market introduction of TCM solutions specifically designed to address neurocognitive disorders and related degeneration. The company places a particular emphasis on conditions such as attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). Established in 2014, Regencell Bioscience maintains its primary office in Causeway Bay, Hong Kong.